Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ) has provided an announcement.
Shandong Xinhua Pharmaceutical Company Limited held an Extraordinary General Meeting (EGM) where all proposed resolutions, including amendments to the articles of association and meeting procedures, were passed. The meeting saw participation from a significant number of shareholders, with a high percentage of votes in favor of the resolutions, indicating strong shareholder support for the company’s governance changes.
More about Shandong Xinhua Pharmaceutical Company Limited Class H
Shandong Xinhua Pharmaceutical Company Limited is a pharmaceutical company based in China, primarily involved in the production and distribution of pharmaceutical products. The company operates within the healthcare industry, focusing on the development and manufacturing of medications.
Average Trading Volume: 3,387,304
Technical Sentiment Signal: Buy
Current Market Cap: HK$10.43B
For a thorough assessment of 0719 stock, go to TipRanks’ Stock Analysis page.